HSPB8 is induced by estrogens and cadmium (a metalloestrogen) in the ER-positive BC MCF-7 cells [25], a process reverted by the pure anti-estrogen ICI182.780 (faslodex, fulvestrant). The gene discussed is HSPB8; the disease is breast cancer.